Inspections, Compliance, Enforcement, and Criminal Investigations

Notification of Stolen Bristol-Myers Squibb Products

Notification of Stolen Bristol-Myers Squibb Products

FDA posts press releases and other notices from firms as a service to consumers, the media, and other interested parties.

Bristol-Myers Squibb (BMS) is working with the U.S. Food and Drug Administration’s Office of Criminal Investigations (FDA), and other law enforcement officials, to recover cases of specified lots of recently stolen pharmaceutical products. The specified lots were being transported in a tractor-trailer stolen in Florence, Kentucky, on Interstate 75 North at around 10 p.m. on Wednesday, November 10, 2010. The trailer contained the products, lots and quantities listed below.

The specified lot numbers are designated solely for the Canadian market and are unique to that market. The lot numbers in question are complete batches; no product with the same lot number had previously been distributed from BMS to any market. The product packaging is in both English and French, as required by Canadian law.

These medicines require a prescription for purchase. Practitioners, pharmacies, and consumers are advised to purchase prescription medicines only from well-established, trusted, and reputable sources and to be aware that an unusually low price is often an indication that a product has been stolen. Additionally, medicines should always be checked for signs of tampering or damage prior to purchase and/or use. Pharmacists and other health care professionals should not use the product if it has been removed from the sealed bottle or container, if the induction seal has been compromised, or in the case of Abilify blister packs, if the foil appears to have been disturbed in any way.

Anyone who has information regarding this incident or has received suspicious or unsolicited offers for the specified BMS products after the date of the theft is encouraged to contact the U.S. Food and Drug Administration (FDA) Office of Criminal Investigations at 1-800-551-3989 or by visiting the OCI Web Site (http://www.fda.gov/OCI).

For medical inquiries about this matter, contact BMS at 1-800-321-1335; for general inquiries, call 1-800-332-2056.

Impacted Products

DescriptionLot Quantity
Abilify 10mg tablets 30's0H53513C4,800
Abilify 10mg tablets 7's SAMPLE0H53513A39,360
Avalide 150/12.5mg tablets 90's0F59141A21,776
Avalide 300/12.5mg tablets 90's0E62462A10,704
Avalide 300/12.5mg tablets 90's0E62463A11,148
Avapro 150mg tablets 90's0J61465A22,293
Coumadin 3mg tablets 100's0H51118B10,238
Plavix 75mg tablets 500's0A059A4,906
Reyataz 300mg capsules 30's0K5011A12,647

Page Last Updated: 01/28/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.